Search results
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
Zacks via Yahoo Finance UK· 4 days agoFollowing the label expansion, AbbVie's (ABBV) Epkinly is the first bispecific antibody approved to...
Julia Louis-Dreyfus Shares Favorite Advice She Has Gotten from Celebrity Women on Her Podcast...
People via Yahoo News UK· 3 days agoFREDERIC J BROWN/AFP via Getty Julia Louis-Dreyfus wins Emmy in 2016 “When you’re in the Marvel...
Euphoria's Lukas Gage packs on PDA with female friends
Daily Mail· 7 days agoNovember, they divorced, with Chris citing 'irreconcilable differences' and Lukas branding his...
How to support performance actors during game development
gamesindustry.biz· 6 days agoHosted by performance capture and voice director Kate Saxon, the panel featured actors Doug Cockle...
‘Jai Palestine’: Why an Indian MP invoked Gaza war while taking oath
Al Jazeera· 6 days agoA usually staid swearing-in procedure where Indian parliamentarians take their oath of office has...
ACC, Clemson fight over court venue. Is there a "homecourt advantage?"
The Post and Courier· 4 days agoOn Feb. 21, a week after the ACC's winter meetings, Cooney and Hooper completed another exchange...
Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
Zacks via Yahoo Finance UK· 4 days agoStrong Q1 Results: Glaukos’ robust first-quarter 2024 results raise investors’ optimism. The company...
Theorycraft Games reveals Project Loki official name SUPERVIVE - Esports Insider
Esports Insider· 6 days agoIndependent game studio Theorycraft Games has officially announced the name of its new competitive...
Teesside's longest established private coach hire firm up for sale after countless miles and...
Teesside Live via Yahoo News UK· 6 days agoThe owner will stay on for a small period to do a handover with a new buyer and introduce them to...
Corcept (CORT) Shares Rise 20% in Three Months: Here's Why
Zacks via Yahoo Finance UK· 5 days agoCorcept's (CORT) pipeline progress has been encouraging with relacorilant currently under evaluation...